Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107655

Stimulators and Inhibitors of Hepatic Porphyrin Formation in Human Sera

Arleen B. Rifkind, Shigeru Sassa, Irwin R. Merkatz, Robert Winchester, Leonard Harber, and Attallah Kappas

Rockefeller University, New York 10021

Department of Obstetrics and Gynecology, Cornell University Medical College, New York 10021

Department of Dermatology, New York University Medical School, New York 10016

Find articles by Rifkind, A. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Department of Obstetrics and Gynecology, Cornell University Medical College, New York 10021

Department of Dermatology, New York University Medical School, New York 10016

Find articles by Sassa, S. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Department of Obstetrics and Gynecology, Cornell University Medical College, New York 10021

Department of Dermatology, New York University Medical School, New York 10016

Find articles by Merkatz, I. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Department of Obstetrics and Gynecology, Cornell University Medical College, New York 10021

Department of Dermatology, New York University Medical School, New York 10016

Find articles by Winchester, R. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Department of Obstetrics and Gynecology, Cornell University Medical College, New York 10021

Department of Dermatology, New York University Medical School, New York 10016

Find articles by Harber, L. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Department of Obstetrics and Gynecology, Cornell University Medical College, New York 10021

Department of Dermatology, New York University Medical School, New York 10016

Find articles by Kappas, A. in: PubMed | Google Scholar

Published April 1, 1974 - More info

Published in Volume 53, Issue 4 on April 1, 1974
J Clin Invest. 1974;53(4):1167–1177. https://doi.org/10.1172/JCI107655.
© 1974 The American Society for Clinical Investigation
Published April 1, 1974 - Version history
View PDF
Abstract

Human sera were found to contain factors that stimulate and factors that inhibit porphyrin formation by cultured avian liver cells. The capacity of sera to stimulate or inhibit porphyrin formation varied in different hormonal states and in the porphyrias. Sera from 31 post partum women, eight of whom were not lactating, inhibited porphyrin formation to a mean level 30% below the level in control cultures and also inhibited drug and steroid stimulation of porphyrin formation. In contrast, mean porphyrin formation compared to control cultures was increased between 9 and 21% by sera from 52 normal subjects, 16 women on oral contraceptives, and 11 pregnant women. It was increased 193% by sera from nine subjects with acute intermittent porphyria and 172% by sera from 13 subjects with porphyria cutanea tarda. Heated sera or ethanol extracts of sera from all groups of subjects further increased the mean porphyrin stimulation by sera and, for the post partum subjects, eliminated the inhibitory effect. Ethanol extracts of sera from 28 oral contraceptive-treated women caused significantly greater mean stimulation of porphyrin formation than did extracts of sera from 30 normal women. While sera from 17 out of 22 porphyric subjects contained both stimulatory and inhibitory factors, 5 out of 22 had no evidence of an inhibitory component. There appeared to be heterogeneity in the occurrence of the factors among porphyrics.

The factor(s) in sera responsible for porphyrin stimulation were heat-stable and insensitive to trypsin; were present in the supernates after ethanol precipitation of plasma proteins; were extractable in ethyl acetate and nondialyzable; and they migrated with the albumincontaining fraction of serum during electrophoresis. The factor(s) responsible for porphyrin inhibition were heat labile, sensitive to trypsin, and resistant to neuraminidase; were present in the ethanol precipitates of sera and were nondialyzable; and they migrated with the gamma globulin fraction of serum during electrophoresis. Inhibition of porphyrin formation was not attributable to heme, free or bound as hemoglobin, hemopexin, or hemalbumin.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1167
page 1167
icon of scanned page 1168
page 1168
icon of scanned page 1169
page 1169
icon of scanned page 1170
page 1170
icon of scanned page 1171
page 1171
icon of scanned page 1172
page 1172
icon of scanned page 1173
page 1173
icon of scanned page 1174
page 1174
icon of scanned page 1175
page 1175
icon of scanned page 1176
page 1176
icon of scanned page 1177
page 1177
Version history
  • Version 1 (April 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts